Items | II group (n = 28) | CI group (n = 23) | Statistics | P |
---|---|---|---|---|
Targeted antimicrobial therapy, n (%) | 16 (57.1) | 18 (78.3) | 2.534 | 0.111 |
Clinical success, n (%) | 8 (50.0) | 13 (72.2) | 1.771 | 0.183 |
G+ bacterial eradication, n (%) | 12 (75.0) | 15 (83.3) | NA | 0.681 |
 Pesumed eradication | 1 (8.3) | 2 (13.3) | NA |  > 0.999 |
 Documented eradication | 11 (91.7) | 13 (86.7) | ||
Adverse reactions, n (%) | Â | Â | Â | Â |
 Leukopenia | 0 (0.0) | 1 (4.4) | NA | 0.462 |
 28-day mortality, n (%) | 5 (17.9) | 5 (21.7) | 0.121 | 0.728 |